Indications
Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium Chloride is a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.
( 1 )
Contraindications
Potassium chloride is contraindicated in patients on potassium sparing diuretics. Concomitant use with potassium sparing diuretics. ( 4 )
Warnings and precautions
Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 )
5.1Gastrointestinal Irritation
May cause gastrointestinal irritation. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .
Interactions
Potassium sparing diuretics: Avoid concomitant use ( 7.1 ) Renin-angiotensin-aldosterone inhibitors: Monitor for hyperkalemia ( 7.2 ) Nonsteroidal Anti-Inflammatory drugs: Monitor for hyperkalemia ( 7.3 )
7.1Potassium-Sparing Diuretics Use
with potassium-sparing diuretics can produce severe hyperkalemia. Avoid concomitant use.
7.2Renin-Angiotensin-Aldosterone System Inhibitors
Drugs that inhibit the renin-angiotensin-aldosterone system (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production. Closely monitor potassium in patients receiving concomitant RAAS therapy.
7.3Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
At a glance
- Brand name
- Pokonza
- Active substance
- potassium chloride
- Route
- Oral
- Dosage form
- For solution
- Applicant
- Genus
- Status
- Prescription
- FDA approval
- 19 Aug 2015
- Application
- NDA208019-004



